Clinical Trials Directory

Trials / Completed

CompletedNCT01123551

Efficacy Study of Nebulized Morphine and Intravenous Morphine in Post Traumatic Pain

Nebulized Morphine Versus Intravenous Morphine in the Management of Post Traumatic Pain in Emergency Department (ED)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
200 (actual)
Sponsor
University of Monastir · Academic / Other
Sex
All
Age
8 Years – 50 Years
Healthy volunteers
Not accepted

Summary

In the emergency department, 60% of patients have an acute pain. Appropriate management of acute pain is a public health priority according to who recommendations. Nebulized morphine has been extensively studied in children but less well in adults. It offers a non-invasive route for systemic drug delivery, more rapid and less invasive than intravenous (IV) method.

Conditions

Interventions

TypeNameDescription
DRUGnebulized morphineAfter randomization, patients will receive 10 mg of morphine (1ml) diluted in 4 ml normal saline and nebulized with 6 l/mn during 10 min. Nebulization will be repeated systematically 3 times every twenty minutes unless the patient pain was resolved (VAPS 30%). In addition, patients receive a bolus of IV placebo(5 ml normal saline . IV placebo (2 ml) will be repeated every 10 minutes if the objective of analgesia was not reached .
DRUGIntravenous morphineAfter randomization, patients will receive a bolus of 5 mg of IV morphine (5 ml. Then, 2mg of IV morphine (2ml) will be added every 10 minutes if the objective of analgesia was not reached (VAPS \>30%). In addition, normal saline (5ml)is nebulized with 6 l/mn during 10 min and will be repeated systematically every 20 minutes unless the patient's pain was not resolved (VAPS \>30%).

Timeline

Start date
2010-06-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2010-05-14
Last updated
2014-07-23

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT01123551. Inclusion in this directory is not an endorsement.